BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yee J, Zasuwa G, Frinak S, Besarab A. Hemoglobin Variability and Hyporesponsiveness: Much Ado About Something or Nothing? Advances in Chronic Kidney Disease 2009;16:83-93. [DOI: 10.1053/j.ackd.2008.12.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Abed M, Artunc F, Alzoubi K, Honisch S, Baumann D, Föller M, Lang F. Suicidal erythrocyte death in end-stage renal disease. J Mol Med (Berl) 2014;92:871-9. [PMID: 24743961 DOI: 10.1007/s00109-014-1151-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
2 Rosati A, Tetta C, Merello JI, Palomares I, Perez-Garcia R, Maduell F, Canaud B, Aljama Garcia P. Cumulative iron dose and resistance to erythropoietin. J Nephrol 2015;28:603-13. [PMID: 25091785 DOI: 10.1007/s40620-014-0127-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fusco G, Hariri A, Vallarino C, Singh A, Yu P, Wise L. A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney disease. Ther Adv Drug Saf 2017;8:305-18. [PMID: 29593859 DOI: 10.1177/2042098617716819] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 de Francisco AL. Individualizing anaemia therapy. NDT Plus 2010;3:519-26. [PMID: 25949459 DOI: 10.1093/ndtplus/sfq164] [Reference Citation Analysis]
5 Singh AK. Resolved: Targeting a Higher Hemoglobin Is Associated with Greater Risk in Patients with CKD Anemia: Pro. JASN 2009;20:1436-43. [DOI: 10.1681/asn.2009040444] [Cited by in Crossref: 20] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Rottembourg JB, Dansaert A. Faisabilité de la stratégie d’administration de la darbepoetin alfa tous les 15 jours : expérience 2005–2007 d’un centre de dialyse. Néphrologie & Thérapeutique 2011;7:549-57. [DOI: 10.1016/j.nephro.2011.03.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Bailey RA, Mcgowan T, Tang KL, Langholff WK, Lantz KC, Wolfson M. Hemoglobin Variability with Extended Dosing of Epoetin Alfa in Patients with Chronic Kidney Disease and Not on Dialysis. Dial Transplant 2009;38:407-11. [DOI: 10.1002/dat.20365] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Rottembourg JB, Kpade F, Tebibel F, Dansaert A, Chenuc G. Stable hemoglobin in hemodialysis patients: forest for the trees--a 12-week pilot observational study. BMC Nephrol 2013;14:243. [PMID: 24180578 DOI: 10.1186/1471-2369-14-243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
9 Levin A, Beaulieu MC. TREAT: Implications for Guideline Updates and Clinical Care. American Journal of Kidney Diseases 2010;55:984-7. [DOI: 10.1053/j.ajkd.2010.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Gaweda AE, Nathanson BH, Jacobs AA, Aronoff GR, Germain MJ, Brier ME. Determining optimum hemoglobin sampling for anemia management from every-treatment data. Clin J Am Soc Nephrol 2010;5:1939-45. [PMID: 20671221 DOI: 10.2215/CJN.03540410] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]